Glaxosmithkline | GSK - Текущие обязательства





Текущие обязательства Изменить Дата
AbbVie USD 42.1B 1.19B 2026-03
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 31.55B 1.02B 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Bausch Health Companies USD 4.53B 350M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Drreddys Laboratories INR 167.57B 165.8B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
Glaxosmithkline GBP 22.43B 6.39B 2026-03
J&J USD 54.9B 2.82B 2026-06
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.75B 374M 2026-06
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 120.92M 18.63M 2026-03
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Takeda JPY 2.76T 335.02B 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Zoetis USD 2.05B 182M 2026-03